Gyermekkori daganatok: vizsgálatok itt: Hollandia
121 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1/2. fázisFut, nem toborozA Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- Where
- Utrecht
- Életkor
- 30 nap and over
- People
- 447 worldwide
- Run by
- Syndax Pharmaceuticals
See details and how to joinNCT04065399 · EU 2024-513759-34-00 - 1. fázisTaking peopleZiftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia
- Where
- Utrecht
- Életkor
- 0 év to 21 év
- People
- 20 worldwide
- Run by
- PedAL BCU, LLC
See details and how to joinNCT06376162 · EU 2023-505262-28-00 - No phaseNot yet taking people in HollandiaOff-line Adaptive Proton Therapy
- Where
- Groningen
- Életkor
- 16 év and over
- People
- 100
- Run by
- University Medical Center Groningen
See details and how to joinNCT07866547 - 1/2. fázisNot yet taking people in HollandiaStudy of the safety and efficacy of asciminib in pediatric and young adult participants with r/r Ph+ or ABL-class Ph-like ALL
- Where
- Utrecht
- Életkor
- Up to 64 év
- People
- 22 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2025-522019-40-00 - 1/2. fázisTaking peopleA Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
- Where
- Utrecht
- Életkor
- 1 hónap to 17 év
- People
- 50 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06941272 · EU 2024-518771-66-00 - 2. fázisNot yet taking people in HollandiaTHRILL: Treat Hyperinflammation in child oncology study
- Where
- Utrecht
- Életkor
- Up to 17 év
- People
- 76
- Run by
- Prinses Maxima Centrum voor Kinderoncologie B.V.
See details and how to join2025-524541-27-00 - 1/2. fázisTaking peopleA Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
- Where
- Amsterdam, Groningen
- Életkor
- 12 év and over
- People
- 359 worldwide
- Run by
- Nuvalent Inc.
See details and how to joinNCT05118789 · EU 2024-511793-71-00 - 2. fázisTaking peopleA Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
- Where
- Utrecht
- Életkor
- 1 év to 17 év
- People
- 100 worldwide
- Run by
- Pfizer
See details and how to joinNCT05748171 · EU 2023-509810-13-00 - 3. fázisTaking peopleCHIP-AML22 Master protocol: Protocol for the treatment of children and adolescents with Acute Myeloid Leukemia (AML)
- Where
- Utrecht
- Életkor
- Up to 64 év
- People
- 675 worldwide
- Run by
- Prinses Maxima Centrum voor Kinderoncologie B.V.
See details and how to join2023-504999-25-00 - 2. fázisTaking peopleLong-Term Follow-Up Study After Gene-Modified Cell Treatment in Kite Studies
- Where
- Amsterdam, Groningen, Nijmegen, Rotterdam, Utrecht
- People
- 1500 worldwide
- Run by
- Kite, A Gilead Company
See details and how to joinNCT05041309 · EU 2023-507041-28-00 - No phaseNot yet taking people in HollandiaEffectiveness of a Visual Telerehabilitation Program on Visual Perception in Children, Adolescents and Young Adults With Hemianopsia Consecutive to a Brain Tumour
- Where
- Utrecht
- Életkor
- 10 év to 40 év
- People
- 120 worldwide
- Run by
- Institut National de la Santé Et de la Recherche Médicale, France
See details and how to joinNCT07558395 - 3. fázisTaking peopleAn international trial for children with atypical teratoid/rhabdoid tumours (ATRT)
- Where
- Groningen, Utrecht
- Életkor
- Up to 17 év
- People
- 301 worldwide
- Run by
- GPOH gGmbH
See details and how to join2022-501456-28-00 - 3. fázisTaking peopleStudy to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
- Where
- Rotterdam, Utrecht
- Életkor
- 12 év to 100 év
- People
- 240 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06784752 · EU 2024-518325-15-00 - 1. fázisTaking peoplePhase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- Where
- Groningen, Leiden
- Életkor
- 12 év to 85 év
- People
- 411 worldwide
- Run by
- Inhibrx Biosciences, Inc
See details and how to joinNCT03715933 · EU 2023-508139-29-00 - No phaseNot yet taking people in HollandiaTargeted Pediatric High-Grade Glioma Therapy
- Where
- Utrecht
- Életkor
- 12 hónap to 39 év
- People
- 350 worldwide
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT05839379 - 3. fázisTaking peopleSIOP RANDOMET 2017
- Where
- Utrecht
- Életkor
- Up to 17 év
- People
- 409 worldwide
- Run by
- GPOH gGmbH
See details and how to join2023-508926-91-00 - 3. fázisTaking peopleSIOP-HRMB: An international prospective trial on clinically high-risk medulloblastoma (HR-MB) in patients older than 3 years.
- Where
- Groningen, Utrecht
- Életkor
- Up to 64 év
- People
- 311 worldwide
- Run by
- The University Of Birmingham
See details and how to join2024-510578-25-00 - 2/3. fázisFut, nem toborozAllogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
- Where
- Utrecht
- Életkor
- 1 hónap to 18 év
- People
- 1800 worldwide
- Run by
- St. Anna Kinderkrebsforschung
See details and how to joinNCT01949129 · EU 2024-512657-24-00 - 2. fázisNot yet taking people in HollandiaStudy of Olutasidenib and Temozolomide in HGG
- Where
- Utrecht
- Életkor
- 12 év to 39 év
- People
- 60 worldwide
- Run by
- Rigel Pharmaceuticals
See details and how to joinNCT06161974 - 2. fázisTaking peopleStudy to evaluate the safety and efficacy of asciminib in pediatric participants with chronic myeloid leukemia.
- Where
- Utrecht
- Életkor
- Up to 17 év
- People
- 16 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2025-522138-29-00 - No phaseTaking peopleCerebellar Mutism Syndrome Study
- Where
- Groningen, Nijmegen, Utrecht
- Életkor
- Up to 18 év
- People
- 2000 worldwide
- Run by
- Copenhagen University Hospital, Rigshospitalet
See details and how to joinNCT02300766 - 3. fázisTaking peopleA Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
- Where
- Utrecht
- Életkor
- 0 év to 45 év
- People
- 6430 worldwide
- Run by
- Mats Heyman
See details and how to joinNCT04307576 · EU 2022-501050-11-01 - 1. fázisCsak meghívásosAdoptive Cell Therapy Long-term Follow-up (LTFU) Study
- Where
- Amsterdam
- People
- 250 worldwide
- Run by
- USWM CT, LLC
See details and how to joinNCT03391778 - 2. fázisTaking peopleA Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
- Where
- Leiden, Utrecht
- Életkor
- 1 év to 39 év
- People
- 105 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT05999994 - 2. fázisNot yet taking people in HollandiaRevumenib Treatment in Combination with FLA Chemotherapy in Paediatric Refractory/Relapsed KMT2A-r, NUP98-r or NPM1-mut Acute Myeloid Leukemia (AML)
- Where
- Utrecht
- Életkor
- Up to 64 év
- People
- 31 worldwide
- Run by
- Pediatric Research International GmbH
See details and how to join2025-521390-14-00